Home › Health › Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Health

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Key Points

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
Adarx Pharmaceuticals (ORG) Upsized US IPO Adarx Pharmaceuticals Inc. (ORG)
Originally published by Bloomberg Markets Read original →